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Abstract
Background: Kurozu concentrated liquid (KCL) is used as a health-promoting supplement for the treatment of
disorders such as cancer, hyperlipidemia, and hypertension in Japan. We investigated the possible anti-obesity
effects of KCL in rats.
Methods: Male Sprague Dawley rats were fed American Institute of Nutrition 76 formula diet and were orally
administrated KCL or acetic acid at a dose of 100 mg/kg body weight or deionized water for 4 weeks. Adipocyte
size, DNA content in subcutaneous adipose tissue, lipid levels in the serum and liver, and the rate of fatty acid
excretion were determined. Effects of KCL on pancreatic lipase activity and 3T3-L1 preadipocyte differentiation
were investigated in vitro.
Results: In the KCL group, the average adipocyte size in subcutaneous and perirenal adipose tissues was
significantly reduced. The KCL-administered rats displayed greater numbers of small adipocytes in the
subcutaneous, perirenal and mesenteric adipose tissues than did rats from the other groups. In the KCL group, the
DNA content in subcutaneous adipose tissue was significantly increased. The rate of fatty acid excretion was
significantly increased in the KCL group. Furthermore, KCL significantly inhibited pancreatic lipase activity in vitro,
and also significantly inhibited fat accumulation and mRNA expression of fatty acid binding protein 2 (aP2) and
peroxisome proliferator-activated g (PPARg) in 3T3-L1 preadipocyte. The levels of serum and liver lipids, the
concentration of serum glucose, and the levels of adiponectin were similar among the 3 groups.
Conclusion: Oral administration of KCL decreases the adipocyte size via inhibition of dietary fat absorption and
reductions of PPARg and aP2 mRNA expression levels in adipocytes.
Introduction
Obesity is a medical condition in which excess body fat
has accumulated to the extent that it has an adverse
effect on health. Obesity, which has an increasing preva-
lence worldwide, is generally recognized as a leading
important cause of metabolic syndrome and is one of
the most serious public health problems in developed
countries [1]. In the development of obesity, the expan-
sion of adipose tissue is initially characterized by an
increase in either the number or size of fat cells [2,3].
Adipocytes are endocrine cells that can be controlled by
the regulation of glucose metabolism, food intake, and
energy expenditure [4]. Moreover, the size of adipocytes
is a major modulator of endocrine function. For exam-
ple, hypertrophic adipocytes secrete greater amounts of
fatty acids and tumor necrosis factor a than do normal
adipocytes. This excess secretion has been hypothesized
to cause insulin resistance [5]. Thus, reduction in adipo-
cyte size plays a key role in preventing obesity and
metabolic syndrome. Recently, an increased number of
people have become interested in the effects of tradi-
tional foods on the inhibition of obesity; thus, the pre-
sent study focused on this function of Kurozu.
Kurozu, which has been used as a health food for a
long time, is brewing rice vinegar that is produced from
unpolished rice with rice bran through static-surface
acetic acid fermentation at the Kagoshima prefecture in
Japan. It is called to as black vinegar (Kurozu in
Japanese), due to its amber color. Kurozu and rice vine-
gars are produced with different raw materials (Kurozu
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polished rice), in addition, brewing process of Koruzu is
very distinctive compared with rice vinegars [6]. The
entire brewing process (saccharification of raw materials,
alcohol fermentation, and acetic acid fermentation) pro-
ceeds spontaneously within the same pot on natural
environment of outdoor for over 1 year. Thus, kurozu
contains more amino acids, vitamins, organic acids and
proteins than rice vinegar [6-8]. Kurozu has been
reported to inhibit tumor growth and nitrotyrosine pro-
duction, promote the activity of matrix metalloprotei-
nase (MMP)-2 and MMP-9, and have orexigenic and
bactericidal functions [9]. It has been shown to prevent
hypertension, improve blood fluidity, and inhibit oxida-
tive action [8]. It has also been reported that the ethyl
acetate extract of Kurozu can prevent skin carcinogen-
esis in mice [10] and azoxymethane-treated rats [11].
Many other biological actions of Kurozu have been
reported, such as liver-specific actions, pharmacological
actions on lipid metabolism, and hemorheological
actions [12]. However, there is no information about the
effect of Kurozu on the reduction of obesity in rats.
In the present study, we investigated the effect of Kur-
ozu concentrated liquid (KCL) on adiposity variables in
Sprague Dawley (SD) rats. Fecal fatty acid excretion,
pancreatic lipase activity, fatty acid binding protein 2
(aP2) and peroxisome proliferator-activated g (PPARg)
mRNA expression during 3T3-L1 preadipocyte differen-
tiation in vitro were determined to clarify the underlying
mechanism of KCL action on adiposity variables.
Materials and methods
Materials
KCL was provided by EGAO Co., Ltd. (Japan). The che-
mical composition of KCL was determined by the offi-
cial method of analysis of Association of Official
Agricultural Chemists (AOAC). KCL contained 56.7%
moisture (AOAC 935.29), 0.9% fat (AOAC 945.16), 2.6%
ash (AOAC 942.05), and 29.8% carbohydrate (Value of
difference between total amount and other all composi-
tions). Total nitrogen content in KCL was 1.63%, it
determined by Kjeldahl method (AOAC 984.13). Pro-
tein, peptide and amino acid contents in KCL were
10.2%, it would estimate by the total nitrogen content
multiplying conversion factor using 6.25.
Diets and animals
Experimental diets were prepared according to the
American Institute of Nutrition (AIN) 76 formula [13]
with modifications. It contained 100 g/kg soy bean oil,
200 g/kg casein, 150 g/kg corn starch, 50 g/kg cellulose,
3 g/kg DL-methionine, 2 g/kg choline bitartrate, 35 g/kg
mineral mixture, 10 g/kg vitamin mixture, and 450 g/kg
sucrose.
Four-week-old male SD rats (n = 21) were obtained
f r o mK y u d oC o . ,L t d .( K u r u m e ,J a p a n ) .T h e s ea n i m a l s
were housed individually in stainless steel cages in an air-
conditioned room (temperature: 21-24°C, with lights on
08:00-20:00 hours). Before the experiment, all the rats
were acclimatized to the laboratory conditions for 3 days,
and they were then divided into 3 groups (control, KCL,
and acetic acid) so that the average body weights were
same for all of these groups. The rats had free access to
deionized water. The diet was given to the rats from 16:00
to 9:00 every day with pair-feeding. We orally adminis-
tered 1 mL samples at 10:00 each day. KCL and acetic
acid dissolved in deionized water were given to the rats at
a dose of 100 mg/kg body weight, and deionized water
was orally administered to the control rats for 4 weeks.
Rat feces were collected for 3 days before the rats
were sacrificed. The rats were fasted for 5 h and then
sacrificed by the removal of blood from the abdominal
aorta under diethyl ether anesthesia. The liver, blood,
right and left leg muscle, white adipose tissues (mesen-
teric, perirenal, retroperitoneal, and epididymal), and
brown adipose tissues were excised and weighed. The
livers were kept at -20°C until analysis. The blood was
kept at room temperature for 30 min and then centri-
fuged at 1000 × g for 10 min to collect the serum. The
supernatant was kept for analysis.
This experiment was carried out according to the
Guidelines for Animal Experiments of the Faculty of
A g r i c u l t u r ea n dt h eG r a d u a t eC o u r s e ,K y u s h uU n i v e r -
sity, Fukuoka, Japan, and Law No. 105 and Notification
No.6 of the Government of Japan.
Glucose tolerance test
During the 3 days before sacrifice, the rats were
deprived of food for 8 h before oral loading with glucose
(6 g/kg body weight) for a glucose tolerance test. Their
blood glucose levels were measured by use of ACCU-
CHEK Compact Plus (Roche diagnostics Co., Ltd,
Tokyo, Japan) at 0, 15, 30, 60, 90, and 120 min after
o r a ll o a d i n g .T h eb l o o dg l u c o s ea r e au n d e rt h ep l a s m a
concentration time curve (blood glucose AUC) was cal-
culated from the blood glucose levels and their time of
determination.
Analysis of morphometric and metabolic parameters
Adipocyte cell size was measured as described elsewhere
[14,2]. Briefly, white adipose tissue and brown adipose
tissue were rinsed with saline solution, fixed in 10%
neutral formalin buffered so l u t i o n ,a n de m b e d d e di n
paraffin. The tissues were then cut into 10-μm sections
and stained with hematoxylin to measure cell size (100
cells/a rat) by National Institutes of Health (NIH) Image
as measuring software. The DNA content of subcuta-
neous adipose tissue was extracted using proteinase K
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obtained DNA was assessed by UV spectrophotometry
at 260 nm in described everywhere.
Serum total cholesterol and high-density lipoprotein
(HDL)-cholesterol levels were measured using enzyme
assay kits from Kainosu Co., Ltd (Tokyo, Japan). Serum
triacylglycerol and phospholipid levels were measured
using enzyme assay kits from Wako Pure Chemicals
(Triglyceride E test and Phospholipids C test; Osaka,
Japan). Serum adiponectin concentration was measured
using an enzyme-linked immunosorbent assay (ELISA)
kit (Mouse/rat adiponectin ELISA kit; Otsuka Pharma-
ceutical, Tokyo, Japan). Liver lipids were extracted by
the method of Folch et al [15]. The levels of total cho-
lesterol, triacylglycerol, and phospholipids were deter-
mined by the method of Sperry and Webb [16], Fletcher
[17], and Wootton [18], respectively.
Feces were lyophilized and weighed. Fecal fatty acids
were analyzed by the method of Ven de Kamer et al
[19], modified by Jeejeebhoy et al [20].
Pancreatic lipase activity in vitro
An emulsion (9 mL) containing 80 mg trioleoylglycerol,
10 mg phosphatidylcholine, and 5 mg sodium taurocho-
late in 0.1 mol/L N-tris (hydroxymethyl) methyl-2-
aminoethane sulfonic acid (TES) buffer (pH 7.0) con-
taining 0.1 mol/L NaCl was prepared by sonication and
was kept at 37°C. A total of 100 μL of the emulsion was
incubated with 50 μL porcine pancreatic lipase (5 U)
(Nakarai Tesque, Kyoto, Japan) solubilized in 0.1 mol/L
TES buffer containing 0.1 mol/L NaCl and various con-
centrations of sample (pH of KCL and acetic acid was
adjusted to 7.0) solutions (100 μL) at 37°C for 30 min.
The amount of released oleic acid was determined
according to the method of Han et al [21].
Cell culture and treatment
The 3T3-L1 preadipocytes (JCRB9014) were maintained in
DMEM (Nissui Co., Ltd Tokyo, Japan) containing 10% calf
serum and 10 mM HEPES, and 10% NaHCO3. The differ-
entiation of preadipocytes was carried out in DMEM
containing 10% fetal bovine serum (FBS), 0.5 mM 3-isobu-
tyl-1-methylxanthine-IBMX (Wako Co., Ltd), 0.25 μm
dexamethasone, and 10 μg/mL insulin for 72 h (phase I).
After 3 days, the preadipocytes treated in phase I were
transferred to DMEM containing 10% FBS for 48 h (phase
II). Acetic acid (3%, used as a negative control) and KCL
(3%) were added to DMEM during phase I or DMEM dur-
ing phase I and II at the same time. The KCL was from
the same lot used in the animal experiments.
Differentiated 3T3-L1 preadipocytes were fixed in 10%
formalin at room temperature for 10 min and then stained
with Oil-Red O (Sigma, St Louis, MO, USA) at 60°C for
15 min after washing with PBS. The 3T3-L1 preadipocytes
were mixed with 4% Nonidet P-40/2-propanol for 15 min
and examined at 492 nm. Total RNA was extracted from
the 3T3-L1 preadipocytes with TRIzol Reagent (Invitro-
gen, Carlsbad, CA, USA). The cDNA was synthesized
from 2.5 μg of total RNA. Gene expression levels were
analyzed by quantitative real-time reverse transcriptase-
polymerase chain reaction (RT-PCR) by using the SYBR
Premix EX Taq II kit and Thermal Cycler Dice Real Time
System TP800 (Takara, Shiga). The expression of aP2 (Pri-
m e r s :f o r w a r d ,5 ’-AACACCGAGATTTCCTT-3’ and
reverse 5’-ACACATTCCACCAC-CAG-3’)a n dP P A R g
(Primers: forward, 5’-AGGCCGAGAAGGAGAAGCTG
TTG-3’ and reverse 5’-TGGCCACCTCTTTGCTCTG
CTC-3’) were analyzed. The mRNA levels were normal-
ized using b-actin (Primers: forward, 5’-CAAAAGCC
ACCCCCACTCCTAAGA-3’ and reverse 5’-GCCCTGGC
TGCCTCAACACCTC-3’).
Statistical analysis
T h ed a t aw e r ee x p r e s s e da sm e a n sw i t hs t a n d a r de r r o r s
and analyzed by Tukey-Kramer’s multiple comparison
post hoc test for the animal experiments and Student’s t
test for the cultured cell experiment. Statistical signifi-
cance was defined as P <0 . 0 5o rP < 0.01. The analysis
was carried out with Excel 2002 (Microsoft, Redmond,
WA, USA).
Results
Growth parameters, adipocyte size and DNA content in
subcutaneous adipose tissue
Body and organ weights and several metabolism-related
indicators and morphometric parameters were measured
in the 3 groups (Table 1). Body weight, food intake, and
feed efficiency were not different among the rats in the
3 groups. Adipose tissue, liver, and leg muscle weights
were not different among the 3 groups.
Compared with the control group, the average adipocyte
size in subcutaneous adipose tissues in the KCL group was
significantly decreased (P < 0.05) (Table 1), but the size in
the acetic acid group was increased (P < 0.05). The average
size in perirenal adipocyte tissues in the KCL group was
reduced significantly compared to that in the control and
acetic acid groups (P < 0.05). Although there were no sig-
nificant differences in the average size in mesenteric adi-
pose tissues between the KCL and control groups, the
average size in the acetic acid group was greater than that
in the KCL group (P = 0.069).
The number of small adipocytes was increased and the
number of large adipocytes was decreased in the subcu-
taneous (Figure 1), perirenal (Figure 2), and mesenteric
(Figure 3) adipocyte tissues in the KCL group compared
with in the control and acetic acid groups. The number
of large adipocytes was greater in the acetic acid group
than in the control group. The DNA content, as an
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pose tissue was significantly increased in the KCL group
than in the control and acetic acid groups.
Serum and liver lipid, serum glucose, and
adiponectin levels
There was no obvious effect of KCL on serum triacylgly-
cerol, total cholesterol, HDL cholesterol, glucose, blood
glucose AUC, and adiponectin levels (Table 1). There
were no significant differences in the liver triacylgly-
cerol, phospholipids, and total cholesterol levels among
the 3 groups.
Feces and fatty acids
The dry weight of the feces was significantly greater in
the KCL group than in the control and acetic acid groups
(Table 1). Likewise, the fecal fatty acid content and the
excretion rate were also significantly higher in the KCL
group than in the control and acetic acid groups.
Pancreatic lipase activity in vitro
We measured the effects of KCL and acetic acid on the
activity of pancreatic lipase in vitro (Figure 4). Addition
of KCL suppressed pancreatic lipase activity in a dose-
dependent manner up to a concentration of 1 mg/mL,
but this effect was not seen when acetic acid was added.
3T3-L1 preadipocyte differentiation and aP2 and
PPARg expression
The fat accumulation of 3T3-L1 preadipocytes in phases
I and I & II was inhibited in the KCL group compared
with that in the acetic acid group (Table 2). Compared
Table 1 Effects of orally administered Kurozu concentrated liquid (KCL) on morphometric and metabolic variables
Control (mean ± SE)* KCL (mean ± SE)* Acetic acid (mean ± SE)*
Food consumption (g/day) 21.0 ±0.4 21.2 ± 0.6 21.2 ± 0.6
Body weight gain (g) 237 ± 7 243 ± 9 240 ± 9
Liver mass (g/100 g body weight) 4.55 ± 0.14 4.60 ± 0.17 4.42 ± 0.16
Leg muscle (g/100 g body weight)
† 1.13 ± 0.09 1.20 ± 0.07 1.20 ± 0.07
Fat mass (g/100 g body weight)
Subcutaneous 4.01 ± 0.23 3.41 ± 0.20 3.57 ± 0.21
Mesenteric 1.16 ± 0.06 1.11 ± 0.07 1.23 ± 0.07
Perirenal 0.453 ± 0.032 0.416 ± 0.034 0.499 ± 0.056
Retroperitoneal 1.79 ± 0.11 1.82 ± 0.12 1.72 ± 0.09
Epididymal 1.45 ± 0.15 1.53 ± 0.16 1.50 ± 0.13
Brown adipose tissue 0.145 ± 0.010 0.132 ± 0.013 0.140 ± 0.009
Total mass 9.02 ± 0.32 8.42 ± 0.33 8.65 ± 0.38
Adipocyte size (μm
2)
Subcutaneous 2895 ± 247
b 1856 ± 269
a 4392 ± 492
c
Perirenal 3869 ± 324
b 2547 ± 330
a 3657 ± 255
b
Mesenteric 1468 ± 133
a, b 1271 ± 96
a 1805 ± 137
b
DNA (μg/g Subcutaneous fat) 16.4 ± 2.5
e 32.0 ± 4.4
d 14.3 ± 2.1
e
Serum
Triacylglycerol (mg/dl) 253 ± 33 249 ± 32 185 ± 27
Total cholesterol (mg/dl) 83.3 ± 9.9 68.5 ± 8.8 74.1 ± 7.4
HDL cholesterol (mg/dl) 48.4 ± 4.7 45.6 ± 5.3 47.8 ± 2.7
Glucose (mg/dl) 140 ± 2 138 ± 4 144 ± 2
Adiponectin (μg/ml) 3.90 ± 0.19 4.48 ± 0.27 4.50 ± 0.37
Blood glucose AUC (mg/dl￿h) 99.8 ± 6.0 104 ± 7 107 ± 13
Liver (mg/g)
Triacylglycerol 24.7 ± 2.6 30.3 ± 5.6 23.5 ± 4.2
Phospholipids 27.8 ± 0.6 25.9 ± 1.4 28.9 ± 0.6
Cholesterol 3.53 ± 0.19 3.11 ± 0.31 3.18 ± 0.42
Fecal mass (g/day) 1.70 ± 0.05
g 1.88 ± 0.03
f 1.73 ± 0.05
g
Fatty acid in feces (mg/day) 86.9 ± 6.4
g 128 ± 7
f 89.1 ± 7.6
g
Fatty acid excretion rate (%/day) 3.91 ± 0.27
g 5.67 ± 0.34
f 3.96 ± 0.41
g
* Means and standard errors (SE) were determined for 7 rats per group. Different superscript letters indicate significant differences at
a,b,cP < 0.05,
f,gP < 0.01,
d,eP
< 0.001.
† Leg muscle mass indicates the sum of quadriceps weight of the right and left legs.
HDL = high-density lipoprotein; AUC = area under the plasma concentration time curve.
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mRNA during phases I and I & II was reduced than in
the KCL group.
Discussion
In the present study, the average size of adipocytes was
significantly smaller in the subcutaneous and perirenal
adipose tissues in the KCL group than in the control
and acetic acid groups, despite the fact that KCL admin-
istration did not change the adipose tissue mass. Reduc-
tion of adipocyte size is meaningful for preventing
obesity because the enlargement of adipose tissue
increased hypertrophy and hyperplasia can cause obesity
[22]. The increase in adipocyte tissue mass in obese
mice is characterized by an increase in adipocyte size up
to a maximum size, followed by an increase in the num-
ber of adipocytes [23]. Hypertrophic adipocytes secrete
growth factors that can trigger adipogenesis through
hyperplasia, and excess secretion has been hypothesized
to cause insulin resistance [5]. In the KCL group, the
number of small adipocytes in the subcutaneous, perire-
nal, and mesenteric adipocyte tissues were increased
while the number of large adipocytes was decreased.
The DNA content reflects number of cells in the tissues.
In the present study, DNA content in the subcutaneous
adipose tissues in KCL group was significantly increased.
Therefore, the adipose tissues in the KCL group pos-
sessed more small cells per a unit than the other groups.
These changes in the adipocyte size distribution profile
were beneficial in the prevention of obesity in SD rats
and obese Zucker rats [2,3]. These results indicate that
KCL plays an important role in regulating the develop-
ment of obesity.
Adipocyte size in the subcutaneous abdominal depot
is an important predictor for the future development of
diabetes mellitus type II in humans [24]. Moreover, the
oral administration of KCL has been reported to
improve diabetes mellitus type II in KKA
y mice [25].
Figure 1 Effect of orally administered Kurozu concentrated liquid (KCL) on cell size in white adipose tissue. Adipocytes are shown in
paraffin sections of subcutaneous (a) adipose tissue (scale bar: 100 μm). The profile of the distribution of the cell size of adipocytes from
subcutaneous (b) adipose tissue. Values are means with standard errors for 7 rats per group. Different characters indicate significant differences
at *P < 0.05, **P < 0.01.
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serum glucose levels and blood glucose AUC levels as
determined by an oral glucose tolerance test among the
3 groups. This is likely because the SD rats used in this
experiment are not diabetic animal model.
Although the detailed mechanisms of the effect of
KCL on the suppression of adipocyte hypertrophy are
unknown, KCL effectively inhibited intestinal absorption
of lipid as shown by an increased excretion of fatty
acids in the feces of rates in the KCL group compared
to in the control and acetic acid groups. These results
show that KCL may inhibit dietary fat absorption, thus,
an effect of KCL on pancreatic lipase activity is to be
investigative, because pancreatic lipase is a key enzyme
that promotes the hydrolysis of triglycerides from diet-
ary fat into fatty acids and 2-monoglycerol which are
then absorbed into intestinal cells [26]. It is clearly
known that dietary fat is not directly absorbed from the
intestine, unless it has been subjected to the action of
pancreatic lipase [27]. Thereby, to improve obesity and
hyperlipidemia, it may be effective to reduce fat absorp-
tion by lipase inhibition [28]. Our data showed that
KCL inhibited pancreatic lipase activity in a dose-depen-
dent manner in vitro. These findings raise the possibility
that KCL is involved in the inhibition of dietary fat
absorption through the inhibition of pancreatic lipase
activity, thereby resulting in an increase in small adipo-
cytes. It has been shown that Kurozu contains phenolic
acid compounds, such as vanillic acid, sinapic acid, and
ferulic acid [8]. These phenolic acids have inhibitory
activity on pancreatic lipase [29].
Both aP2 and PPARg, which are key regulatory factors
in adipogenesis, are primarily found in adipose tissue.
Reductions in aP2 and PPARg mRNA expressions are
Figure 2 Effect of orally administered Kurozu concentrated liquid (KCL) on cell size in white adipose tissue. Adipocytes are shown in
paraffin sections of perirenal (a) adipose tissue (scale bar: 100 μm). The profile of the distribution of the cell size of adipocytes from perirenal (b)
adipose tissue. Values are means with standard errors for 7 rats per group. Different characters indicate significant differences at *P < 0.05,
**P < 0.01.
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Page 6 of 9Figure 3 Effect of orally administered Kurozu concentrated liquid (KCL) on cell size in white adipose tissue. Adipocytes are shown in
paraffin sections of and mesenteric (a) adipose tissue (scale bar: 100 μm). The profile of the distribution of the cell size of adipocytes from
mesenteric (b) adipose tissue. Values are means with standard errors for 7 rats per group. Different characters indicate significant differences at
*P < 0.05, **P < 0.01.
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Figure 4 Effect of Kurozu concentrated liquid (KCL) on the
activity of pancreatic lipase in vitro. Values are means with
standard errors for triplicate experiment.
Table 2 Effect of Kurozu concentrated liquid (KCL) on
3T3-L1 preadipocyte differentiation and the expression
of fatty acid binding protein 2 (aP2) and peroxisome
proliferator-activated g (PPARg) mRNA during 3T3-L1
preadipocyte differentiation
Phase I (mean ± SE) Phase I & II (mean ± SE)
Acetic acid KCL Acetic acid KCL
Absorbance 0.139 ±
0.002
a
0.124 ±
0.004
0.135 ±
0.001
b
0.125 ±
0.001
aP2/b-actin (%) 73.7 ± 0.7
b 56.0 ± 2.8 108 ± 1
c 32.7 ± 0.5
PPARg/b-actin
(%)
1.74 ± 0.03
c 0.943 ±
0.032
1.36 ± 0.04 N.D.
Differentiated cells were stained with Oil Red O and their absorbance was
determined at 492 nm. In the determination of mRNA levels, b-actin was used
as a loading control. The means and standard errors (SE) are for triplicate
experiments. Different superscript letters indicate significant differences at
aP
< 0.05,
bP < 0.01,
cP < 0.001. N.D.; not detected.
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[5,30,31]. In the present study, the KCL group reduced
accumulation of fat and mRNA expression of aP2 and
PPARg in the 3T3-L1 preadipocyte compared with the
acetic acid group. It has been reported that phenolic
acids contained in KCL, such as ferulic acid, sinapic
acid, and vanillic acid [8], may play a role in the control
of adipogenesis by inhibiting the mRNA expression of
PPARg in 3T3-L1 cells [32]. The phenolic acids con-
tained in KCL may inhibit hypertrophy of adipocyte in
3T3-L1 cells. Therefore, KCL may contribute to the
decreased adipocyte size seen by inhibiting aP2 and
PPARg mRNA expression in vivo.
Acetic acid has been reported to be an effective compo-
nent of metabolic regulation. In fact, dietary acetic acid
has been reported to reduce serum total triacylglycerol
and cholesterol levels in rats, and reduced obesity and
obesity-linked type II diabetes in Otsuka Long-Evans
Tokushima Fatty rats [33-35]. In a human study, acetic
acid intake reduces serum total triacylglycerol and body
weight in obese Japanese [36]. In the present study, the
rats given acetic acid had similar levels of glucose and
lipids in their serum and liver as did the control rats. The
average adipocyte size in the subcutaneous adipose tissue
of rats in the acetic acid group was greater than that in
the control and KCL groups. In addition, acetic acid
had no significant effect on pancreatic lipase activity.
The obtained results clearly showed that acetic acid did
not play a role in responsible for decreasing the size of
adipocytes on development of obesity in SD rats fed a
10% fat diet.
Conclusions
In summary, the results of the present study indicate that
KCL decreases the adipocyte size via inhibition of dietary
fat absorption and reductions of PPARg and aP2 mRNA
expression levels. Moreover, acetic acid as a component
in KCL does not play a role in decreasing the adipocytes
size on development of obesity in SD rats.
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